Facebook continues to dominate pharmaceutical social media, new report reveals

By Catherine Sturman
A report by Ogilvy Healthworld and data specialists Pulsar has highlighted how the pharmaceutical landscape continues to transform in alignment with the...

A report by Ogilvy Healthworld and data specialists Pulsar has highlighted how the pharmaceutical landscape continues to transform in alignment with the growth of social media and continued consumer engagement.

With data taken from 2016 and 2017, the duo analysed over 20 pharmaceutical companies and their use of social media platforms, such as Facebook, Twitter, Instagram and YouTube.

Chloe Partikas, Social Media Director at Ogilvy Healthworld, said: "It is clear that the pharma social media space is changing. Pharma is reaching social media maturity, posting more strategically and tailoring content to the channel and audiences."

Whilst all usage of social media channels by pharma companies have decreased since 2016, the use of YouTube across the industry has risen by 8%, reflecting changing consumer tastes from content which is linear, to the growing popularity of digital, visual content.

See also

The number of followers across the majority of platforms also grew, with the use of Facebook within both the corporate and consumer space remaining constant throughout the year.

Finding an increased use of visual content, Instagram is slowly creeping up behind Facebook and is becoming a favoured consumer engagement platform of choice. Pharmaceutical companies received up to 190 average number of engagements per post, a significant increase from previous years.

Additionally, Novo Nordisk has taken the lead in company engagement and activity across its platforms with a 13% rise, with Johnson & Johnson and Novartis following swiftly behind with regards to the consumer engagement, receiving a 111% and 77% rise over the last 12 months alone.

In stark contrast, Takeda, Gilead, Sanofi, Amgen and AstraZeneca were named as some of the pharmaceutical companies with the lowest number of posts and social engagement across all digital platforms.

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI